Evidence map›Paper›PMID 29769579›Full record

ArticleScientific reports2018

HLA-class II haplotypes and Autism Spectrum Disorders.

Meriem Bennabi, Alexandru Gaman, Richard Delorme, Wahid Boukouaci, Céline Manier, Isabelle Scheid, Nassima Si Mohammed, Djaouida Bengoufa, Dominique Charron, Rajagopal Krishnamoorthy and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 5 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 5 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genetic relationship between the immune system and autism.Brain, behavior, & immunity - health · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?International journal of molecular sciences · 2022
    Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Meriem BennabiINSERM, U1160, Hôpital Saint Louis, Paris, France.
Alexandru GamanINSERM, U955, Psychiatrie Translationnelle, Créteil, France.
Richard DelormeFondation FondaMental, Créteil, France.
Wahid BoukouaciINSERM, U1160, Hôpital Saint Louis, Paris, France.
Céline ManierINSERM, U1160, Hôpital Saint Louis, Paris, France.
Isabelle ScheidINSERM, U955, Psychiatrie Translationnelle, Créteil, France.
Nassima Si MohammedFondation FondaMental, Créteil, France.
Djaouida BengoufaLaboratoire Jean Dausset and LabEx Transplantex, Hôpital Saint Louis, Paris, France.
Dominique CharronINSERM, U1160, Hôpital Saint Louis, Paris, France.
Rajagopal KrishnamoorthyINSERM, U955, Psychiatrie Translationnelle, Créteil, France.
Marion LeboyerINSERM, U955, Psychiatrie Translationnelle, Créteil, France.
Ryad TamouzaINSERM, U1160, Hôpital Saint Louis, Paris, France. tamouza.ryad@gmail.com.
Inserm · FRFondation FondaMental · FRHôpital Saint-Louis · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infections and autoimmunity are associated with autism spectrum disorders (ASD), with both strongly influenced by the genetic regulation of the human leukocyte antigen (HLA) system. The relationship between ASD and the HLA genetic diversity requires further investigation. Using a case control design, the distribution of HLA class II-DRB1 and DQB1 alleles, genotypes and haplotypes were investigated in ASD patients, versus healthy controls (HC). ASD patients meeting DSM-IV TR criteria and HC (474 and 350 respectively) were genotyped at medium resolution using a Luminex-based SSO technology. Comparisons of genotypes, allele frequencies associated with a haplotype analysis were performed. Results indicate: (i) the HLA-DRB1 *11-DQB1*07 haplotype was more prevalent in ASD patients, versus HC (Pc = 0.001), partially replicating previous data and possibly linking to gastro-intestinal (GI)-related pro-inflammatory processes, given that this haplotype associates with pediatric celiac disorders; (ii) the HLA-DRB1 *17-DQB1*02 haplotype was higher in HC, versus ASD patients (Pc = 0.002), indicating that this is a protective haplotype. Using the Autism Diagnostic Interview to assess clinical dimensions, higher scores on social (Pc = 0.006) and non-verbal functioning (Pc = 0.004) associated with the DRB1 *11 DQB1*07 haplotype. Our results support HLA involvement in ASD, with possible relevance to GI and gut-brain axis dysregulation.

Indexed as

Polymorphism, GeneticAdolescentAdultAgedAutism Spectrum DisorderCase-Control StudiesChildChild, PreschoolFemaleGenotypeHaplotypesHistocompatibility Antigens Class IIHumansMaleMiddle AgedPrognosisHistocompatibility Antigens Class II

Identifiers

PMID29769579
PMCPMC5955937
OpenAlexW2804042682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.